Valuation Zenotech Laboratories Limited

Stocks

Delayed Bombay S.E. 12:51:06 07/10/2026 +04			5-day change	1st Jan Change
41.70 ^INR	-0.24%		-0.31%	-9.72%

07-28	Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
04-29	Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	2,136	3,073	2,872	3,608	3,169	2,093
Change	-	43.86%	-6.53%	25.61%	-12.16%	-33.96%
Enterprise Value (EV) ¹	2,318	3,109	2,761	3,411	2,902	1,788
Change	-	34.11%	-11.2%	23.54%	-14.92%	-38.36%
P/E	-175x	13.9x	24.8x	43.5x	56.5x	-191x
PBR	4.41x	4.35x	3.49x	3.98x	3.3x	2.2x
PEG	-	-0x	-0.5x	-1.5x	-1.7x	2x
Capitalization / Revenue	11x	9.33x	7.36x	9.8x	8.1x	5.21x
EV / Revenue	12x	9.44x	7.08x	9.27x	7.42x	4.45x
EV / EBITDA	36.3x	17.4x	12.9x	19.8x	20.3x	18.1x
EV / EBIT	-3,050x	28.4x	19.5x	33.5x	39.4x	64.9x
EV / FCF	-148x	26.6x	26x	71.4x	73.4x	-132x
FCF Yield	-0.68%	3.75%	3.84%	1.4%	1.36%	-0.76%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.2	3.63	1.898	1.36	0.9197	-0.18
Distribution rate	-	-	-	-	-	-
Net sales ¹	193.7	329.5	390.1	368.1	391	401.6
EBITDA ¹	63.8	179.2	213.6	172.6	143.2	98.69
EBIT ¹	-0.76	109.4	141.9	101.8	73.6	27.56
Net income ¹	-12.15	221.8	115.9	82.99	56.13	-10.72
Net Debt ¹	182	35.85	-111.4	-196.9	-267	-304.2
Reference price ²	35.00	50.35	47.06	59.11	51.92	34.29
Nbr of stocks (in thousands)	61,031	61,031	61,031	61,031	61,031	61,031
Announcement Date	02/09/21	30/08/22	05/09/23	02/09/24	01/09/25	28/08/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ZENOTECH LABORATORIES LIMITED	-	-	-	-	26.46M
ELI LILLY AND COMPANY	32.87x	11.93x	24.1x	0.6%	1,032B
JOHNSON & JOHNSON	28.34x	6.29x	17.98x	2.1%	614B
ABBVIE INC.	37.73x	7.89x	16.32x	2.6%	471B
MERCK & CO., INC.	103.26x	5.79x	24.59x	2.4%	350B
ROCHE HOLDING AG	19.01x	4.63x	11.48x	2.86%	337B
NOVARTIS AG	19.87x	5.19x	12.84x	3.07%	268B
ASTRAZENECA PLC	20.52x	4.22x	12.02x	2.1%	246B
AMGEN INC.	25.43x	6.65x	11.85x	2.51%	218B
GILEAD SCIENCES, INC.	-43.62x	6.37x	24.89x	2.28%	179B
Average	27.04x	6.55x	17.34x	2.28%	371.49B
Weighted average by Cap.	32.24x	7.67x	18.71x	1.95%